Storia della carriera di F. Andrew Dorr
Precedenti posizioni note di F. Andrew Dorr
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| SPYRE THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | - | 21/04/2017 |
Salmedix, Inc.
 Salmedix, Inc. Pharmaceuticals: MajorHealth Technology Salmedix, Inc. develops oncology and small molecule drugs to treat hematological malignancies. The company's product, Treanda, is currently in Phase II clinical trials in the United States and Canada for the treatment of indolent (slowly progressing) non-Hodgkin's lymphoma. It was founded in 2000 and is located in San Diego, CA. | Direttore operativo | 01/08/2004 | 01/08/2004 |
| IONIS PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 01/01/1996 | 01/01/2003 |
Formazione di F. Andrew Dorr
| Davidson College | Undergraduate Degree |
| The University of North Carolina at Charlotte | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
Posizioni
| Chief Tech/Sci/R&D Officer | 2 |
| Chief Operating Officer | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| SPYRE THERAPEUTICS, INC. | Health Technology |
| IONIS PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Salmedix, Inc.
Salmedix, Inc. Pharmaceuticals: MajorHealth Technology Salmedix, Inc. develops oncology and small molecule drugs to treat hematological malignancies. The company's product, Treanda, is currently in Phase II clinical trials in the United States and Canada for the treatment of indolent (slowly progressing) non-Hodgkin's lymphoma. It was founded in 2000 and is located in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- F. Andrew Dorr
- Esperienza
